Drug intelligence / Profile preview

Softmega

Development stage
Unknown
Lead developer
Biokindle Lifesciences
Modality
Small Molecules
Administration
Oral
01

Overview

Softmega (also marketed as Softmega Forte) is a nutritional supplement and nutraceutical developed by Biokindle Lifesciences Pvt Ltd. It contains omega-3 marine triglycerides, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), derived from marine sources and formulated as oral softgel capsules. The product is indicated as an adjunct to diet to reduce plasma triglyceride levels in patients with hypertriglyceridemia and for the management of cardiovascular and renal conditions. Its mechanism of action involves providing essential omega-3 fatty acids that modulate lipid metabolism to lower triglycerides and exert anti-inflammatory effects. In nephrology, Softmega is used to support kidney function, reduce the prevalence of chronic kidney disease (CKD), and potentially slow the progression of IgA nephropathy.

Brand names
SoftmegaSoftmega Forte
Other names
omega-3 marine triglyceridesomega3 marine triglyceridesomega 3 marine triglycerides
02

Targets

Cell membrane phospholipid

Beyond the preview

Go deeper on Softmega.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Softmega.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call